Medicines Co. (MDCO) Tops Q4 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
The Medicines Company Reports Fourth-Quarter and Full-Year 2015 Business and Financial Results
February 17, 2016 7:02 AM ESTRecent data presentations highlight pipeline progress and potential New-product revenues increasing Strategy to deploy capital against highest value assets on track with the divestiture of hemostasis portfolio
PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today announced its business and financial results for the fourth quarter and full year ended December 31, 2015.
During and since the fourth quarter of 2015, the Company has:
ALN-PCSsc: Announced positive results from the Phase 1 study of ALN-PCSsc at the American... More